Transcatheter Cardiovascular Therapeutics (TCT) conference 2018

Abstract

The 30th annual Transcatheter Cardiovascular Therapeutics (TCT) conference 2018 held in sunny San Diego, California, was replete with surprises. The landmark COAPT trial was a clear home run, showcasing that transcatheter mitral valve approximation using the MitraClip, on a background of maximally tolerated guideline-directed medical therapy (GDMT) was superior to GDMT alone in the reduction of Heart Failure (HF) hospitalization and mortality in symptomatic heart failure patients with grade 3-4+ Mitral regurgitation (MR).